CN Patent

CN114762684B — 一种治疗帕金森的缓释胶囊及其制备方法

Assigned to Huayi Taikang Pharmaceutical Co ltd · Expires 2023-11-21 · 2y expired

What this patent protects

本发明属于医药技术领域，具体涉及一种治疗帕金森的缓释胶囊及其制备方法。本发明所述胶囊剂包括：(1)速释小丸，其至少含有两种活性成分；(2)缓释小丸，其由内向外依次包括：速释小丸和缓释层；以及(3)空白小丸。本发明缓释胶囊成本较低、治疗效果好，可以显著减轻患者的用药负担。

USPTO Abstract

本发明属于医药技术领域，具体涉及一种治疗帕金森的缓释胶囊及其制备方法。本发明所述胶囊剂包括：(1)速释小丸，其至少含有两种活性成分；(2)缓释小丸，其由内向外依次包括：速释小丸和缓释层；以及(3)空白小丸。本发明缓释胶囊成本较低、治疗效果好，可以显著减轻患者的用药负担。

Drugs covered by this patent

Patent Metadata

Patent number
CN114762684B
Jurisdiction
CN
Classification
—
Expires
2023-11-21
Drug substance claim
No
Drug product claim
No
Assignee
Huayi Taikang Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.